FLYE Investors Have Opportunity to Lead Fly-E Group, Inc. Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit againstFly-E Group, Inc. (“Fly-E” or “the Company”) (NASDAQ: FLYE) forviolations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. https://mma.prnewswire.com/media/1396534/Schall_Firm_Logo.jpg Investors who purchased the […]

Tronox Holdings plc Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – TROX

The DJS Law Group reminds investors of a class action lawsuit against Tronox Holdings plc (“Tronox” or “the Company”) (NYSE: TROX ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of TROX during the

Changsha: A City Brimming with Youthful Vitality

A news report from China Daily: From steaming morning bowls to sizzling midnight markets, the pulse of #Changsha never stops. This is a city where a millennium of craftsmanship inspires smart manufacturing, and where dreams are launched under fireworks over the Xiang River. Truly, a bridge from a rich past to a dynamic future. #MyChinaSuprise

SIGRID Expands into the U.S. Physician Channel Following Successful Pilot Program

SIGRID, the Swedish innovative consumer care company behind the groundbreakingGlucose Stabiliserpowered by patentedSiPore®technology, today announced itsexpansion into the U.S. physician channel following a successful pilot programwith selected integrative and functional medicine clinics. https://mma.prnewswire.com/media/2811024/SIGRID_Glucose_Stabiliser.jpg As part of this initiative, SIGRID has partnered with an experienced industry insider to establish a dedicated sales infrastructure designed specifically for

bp unlocks value, divests non-controlling interests in US onshore midstream assets for $1.5 billion

— bp divests non-controlling interests in Permian and Eagle Ford midstream assets to private investor Sixth Street for $1.5 billion — Agreement enables bp to unlock capital from infrastructure, while retainingoperatorship and control of strategic midstream assets — Transaction delivers a material contribution towardsbp's 2025 expected divestment proceeds and target of $20 billion of divestments

INSEAD celebrates 25th anniversary of Asia Campus: Leading the future of business education from Singapore

INSEAD, The Business School for the World, marks the25th anniversary of its Asia Campus in Singapore. This milestone celebrates a quarter-century of pioneering business education in Asia and sets the stage for the next chapter in global leadership. Twenty-five years ago, INSEAD made a bold decision to establish a second full-fledged campus, based in Singapore,

Arctic Therapeutics Receives EMA Approval for Phase IIa Study of AT-001 in Alzheimer’s Disease

— The European Medicines Agency (EMA) authorises initiation of a Phase IIa study evaluating AT-001 in patients diagnosed with Alzheimer's disease — EMA grants Orphan Drug Designation (ODD) to AT-001 for hereditary cystatin C amyloid angiopathy (HCCAA), a rare familial dementia Arctic Therapeutics (ATx), an Iceland-based clinical-stage biopharmaceutical company, today announced key regulatory milestones for

Sandstone Easydrip™ Plus with Hextra Tech™ Hexagonal Broad Hub Delivers Steadier, More Comfortable Insulin Injections

A peer-reviewed article by researchers at the University of Shanghai for Science and Technology (USST), published in an international biomedical engineering journal, reports that the Hextra Tech™ hexagonal, broad-platform hub used inSandstone Easydrip™ Plus pen needles improves injection stability and user comfort versus conventional narrow hubs in laboratory bench tests. The study measured lower needle

Omni Bridgeway Delivers Strong 1Q26 Performance and Strategic Momentum

Omni Bridgeway Limited (ASX: OBL), a global leader in legal asset management, today announced strong results for the first quarter of FY26, underscoring continued execution of its growth strategy and operational discipline. https://mma.prnewswire.com/media/1735666/OB_Logo_stacked_CMYK_full_color_Logo.jpg Key Highlights — Income Growth: A strong quarter delivering A$136 million in cash investment proceeds, achieving a 2.8x MOIC and 102% fair

Molina Healthcare, Inc. (MOH) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – Robbins Geller Rudman & Dowd LLP

The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Molina Healthcare, Inc. (NYSE: MOH) securities between February 5, 2025 and July 23, 2025, both dates inclusive (the “Class Period”), have until Tuesday, December 2, 2025 to seek appointment as lead plaintiff of the Molina class action lawsuit. Captioned

Scroll to Top